Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jul;65(7):3647-55.
doi: 10.1128/JVI.65.7.3647-3655.1991.

Negative regulation of the BZLF1 promoter of Epstein-Barr virus

Affiliations

Negative regulation of the BZLF1 promoter of Epstein-Barr virus

E A Montalvo et al. J Virol. 1991 Jul.

Abstract

The Epstein-Barr virus BZLF1 gene product (ZEBRA) is a transcriptional activator whose expression in latently infected B cells is sufficient to induce the viral lytic cycle. Since there is no transcription of BZLF1 during latency, we carried out experiments to determine whether cis-acting negative elements in the BZLF1 promoter contribute to the lack of expression during this phase of the virus cycle. A series of deletion plasmids encompassing positions -551 to +14 of the BZLF1 promoter region were constructed and tested for the ability to drive chloramphenicol acetyltransferase (CAT) gene expression in the absence of inducing agents such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and anti-immunoglobulin. Expression from the intact 551-bp region was very weak in most of the cell lines tested, but deletion of 165 bp from the 5' end caused a sevenfold increase in expression of CAT. Within these 165 bp, a minimal 48-bp region was sufficient to down regulate the expression of a simian virus 40/CAT fusion plasmid. The 48-bp negative element consists of 7-bp dyad symmetry elements separated by 27 bp. The rightmost half of the dyad symmetry element partially overlaps a region which has a 14-of-15-bp homology to the human cytoskeletal gamma-actin promoter.

PubMed Disclaimer

References

    1. J Virol. 1989 Apr;63(4):1729-36 - PubMed
    1. EMBO J. 1989 May;8(5):1447-53 - PubMed
    1. EMBO J. 1989 Jan;8(1):127-32 - PubMed
    1. Cell. 1989 Dec 22;59(6):987-97 - PubMed
    1. Cell. 1989 Dec 22;59(6):979-86 - PubMed

Publication types

MeSH terms

LinkOut - more resources